Structures by: Jasinski J. P.
Total: 594
C27H26N4O8S,CH2Cl2
C27H26N4O8S,CH2Cl2
Green Chemistry (2012) 14, 11 3010
a=11.5934(4)Å b=23.9267(7)Å c=12.5474(5)Å
α=90.00° β=116.043(4)° γ=90.00°
C20H21N5O4
C20H21N5O4
Green Chem. (2016) 18, 9 2642
a=9.9263(3)Å b=15.4568(5)Å c=12.4445(4)Å
α=90° β=96.737(3)° γ=90°
C54H50Br2Cu2N4P2S2
C54H50Br2Cu2N4P2S2
New Journal of Chemistry (2018) 42, 12 9886
a=10.5137(3)Å b=20.7529(6)Å c=11.7654(3)Å
α=90° β=103.798(3)° γ=90°
C9H11ClCuN4S,C2H3N
C9H11ClCuN4S,C2H3N
New Journal of Chemistry (2018) 42, 19 15879
a=8.5331(7)Å b=9.4698(7)Å c=9.5110(7)Å
α=96.619(6)° β=98.510(6)° γ=102.123(7)°
C9H11BrCuN4S
C9H11BrCuN4S
New Journal of Chemistry (2019) 43, 29 11727
a=8.0789(3)Å b=16.0989(6)Å c=9.3280(3)Å
α=90° β=94.092(3)° γ=90°
C8H9BrCuN4S
C8H9BrCuN4S
New Journal of Chemistry (2019) 43, 29 11727
a=18.4808(4)Å b=7.84160(10)Å c=16.8857(4)Å
α=90° β=117.093(3)° γ=90°
C41H34AgN4P2S,NO3
C41H34AgN4P2S,NO3
RSC Advances (2019) 9, 27 15470
a=9.2210(3)Å b=25.4962(8)Å c=17.0609(5)Å
α=90° β=100.830(3)° γ=90°
(3aS,3cS,6aR,7S,9S,9aR)-methyl 2,5-diethyl-7,9-di(furan-2-yl)- 1,3,4,6-tetraoxododecahydro-1H-dipyrrolo[3,4-a:3',4'-f] pyrrolizine-3b-carboxylate
C25H25N3O8
Green Chemistry (2012) 14, 11 3010
a=10.8016(4)Å b=23.0207(5)Å c=9.9117(3)Å
α=90.0° β=111.566(4)° γ=90.0°
6-(4-Bromo-phenyl)-3-fluoro-5-nitro-2-oxo-4-phenyl-piperidine-3-carboxylic acid ethyl ester
C20H18BrFN2O5
RSC Adv. (2015)
a=22.744(3)Å b=7.5503(4)Å c=16.0634(18)Å
α=90° β=131.075(18)° γ=90°
2(C79H60Cu4N12O15),4(NO3),7(H2O)
2(C79H60Cu4N12O15),4(NO3),7(H2O)
Dalton Trans. (2017)
a=12.7802(3)Å b=18.3127(4)Å c=20.1463(6)Å
α=110.553(2)° β=105.564(2)° γ=95.942(2)°
C80H62Cu4N12O13,2(NO3)
C80H62Cu4N12O13,2(NO3)
Dalton Trans. (2017)
a=13.5950(6)Å b=31.2519(19)Å c=19.8980(7)Å
α=90° β=99.454(4)° γ=90°
C12H24ClCuN4S2
C12H24ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=14.0097(4)Å b=14.0814(3)Å c=18.9263(6)Å
α=90° β=108.984(3)° γ=90°
C42H79.76Cl6Cu6N12S6
C42H79.76Cl6Cu6N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=17.5632(7)Å b=17.5632(7)Å c=17.7092(9)Å
α=90° β=90° γ=120°
C54H60Cu4I4N12S6
C54H60Cu4I4N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=9.573(4)Å b=10.198(5)Å c=16.821(8)Å
α=100.18(2)° β=99.48(3)° γ=98.79(3)°
C10H20CuIN4S2
C10H20CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.6359(7)Å b=7.3154(5)Å c=26.7530(18)Å
α=90.00° β=95.591(3)° γ=90.00°
C18H20ClCuN4S2
C18H20ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.5161(5)Å b=10.4367(5)Å c=28.1083(14)Å
α=90° β=92.378(5)° γ=90°
C8H16ClCuN4S2
C8H16ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=12.9744(16)Å b=7.6298(10)Å c=14.1661(16)Å
α=90° β=105.936(13)° γ=90°
C20H36Cu5I6N8S2
C20H36Cu5I6N8S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.0690(4)Å b=9.9078(6)Å c=13.1167(8)Å
α=99.126(5)° β=102.165(5)° γ=111.425(5)°
C36H40Br2Cu2N8S4
C36H40Br2Cu2N8S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6581(17)Å b=12.6438(15)Å c=19.708(2)Å
α=90.00° β=94.694(4)° γ=90.00°
C9H10CuIN2S
C9H10CuIN2S
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6938(9)Å b=12.7042(6)Å c=11.1498(6)Å
α=90° β=95.604(5)° γ=90°
C8H16BrCuN4S2
C8H16BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.2573(9)Å b=7.4836(5)Å c=14.3879(10)Å
α=90° β=107.330(7)° γ=90°
C8H16CuIN4S2
C8H16CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.710(3)Å b=7.422(4)Å c=14.723(2)Å
α=90.00° β=109.448(5)° γ=90.00°
JPL-212
C14H28BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.3515(4)Å b=10.0895(5)Å c=14.3386(6)Å
α=102.109(4)° β=101.930(4)° γ=100.673(4)°
C26H30Cl2N3V1
C26H30Cl2N3V1
Dalton transactions (Cambridge, England : 2003) (2010) 39, 14 3482-3488
a=8.3520(17)Å b=8.7980(18)Å c=18.550(4)Å
α=79.78(3)° β=89.34(3)° γ=72.16(3)°
C21H25N2,C5H5Cl3V
C21H25N2,C5H5Cl3V
Dalton transactions (Cambridge, England : 2003) (2010) 39, 14 3482-3488
a=29.543(6)Å b=14.710(3)Å c=14.792(3)Å
α=90.00° β=94.19(3)° γ=90.00°
C40H33CuN2P2S
C40H33CuN2P2S
RSC Advances (2014) 4, 58 30511
a=9.349(3)Å b=11.140(4)Å c=18.860(6)Å
α=93.050(13)° β=92.208(12)° γ=113.907(11)°
C41H33CuN4P2S,CH4O
C41H33CuN4P2S,CH4O
RSC Advances (2014) 4, 58 30511
a=9.0783(2)Å b=25.2036(6)Å c=16.9815(5)Å
α=90.00° β=102.171(3)° γ=90.00°
C40H34ClCuN2OP2S
C40H34ClCuN2OP2S
RSC Advances (2014) 4, 58 30511
a=10.8164(9)Å b=13.1393(10)Å c=14.7805(10)Å
α=76.189(6)° β=81.704(6)° γ=67.452(7)°
C76H63ClCu2N2P4S2
C76H63ClCu2N2P4S2
RSC Advances (2014) 4, 58 30511
a=17.6065(5)Å b=18.9904(6)Å c=22.8262(7)Å
α=66.994(3)° β=69.512(3)° γ=81.169(3)°
C76H63BrCu2N2P4S2
C76H63BrCu2N2P4S2
RSC Advances (2014) 4, 58 30511
a=17.5439(3)Å b=18.7998(3)Å c=22.7125(4)Å
α=67.538(2)° β=69.421(2)° γ=80.7420(10)°
C111H92Br2Cu3N3P6S3
C111H92Br2Cu3N3P6S3
RSC Advances (2014) 4, 58 30511
a=12.8825(5)Å b=13.2054(5)Å c=33.4043(11)Å
α=93.223(3)° β=96.511(3)° γ=119.084(4)°
(C39H32CuN3P2S3),1/2(H2O)
(C39H32CuN3P2S3),1/2(H2O)
RSC Advances (2014) 4, 58 30511
a=12.864(4)Å b=16.167(5)Å c=17.506(5)Å
α=90° β=95.271(4)° γ=90°
C46H36Cu2N8P2S2
C46H36Cu2N8P2S2
RSC Advances (2014) 4, 58 30511
a=12.6132(6)Å b=12.6674(6)Å c=17.0373(7)Å
α=88.319(3)° β=69.754(4)° γ=65.581(4)°
4(C18H14CuN6O3S),3(CH4O)
4(C18H14CuN6O3S),3(CH4O)
RSC Adv. (2015)
a=16.3302(4)Å b=20.2955(5)Å c=25.5819(7)Å
α=90.00° β=107.3830(10)° γ=90.00°
C19H16CuN6O3S
C19H16CuN6O3S
RSC Adv. (2015)
a=8.073(2)Å b=9.391(3)Å c=13.924(4)Å
α=71.441(15)° β=85.420(15)° γ=75.557(16)°
C21H16CuN6O3S
C21H16CuN6O3S
RSC Adv. (2015)
a=5.9763(5)Å b=11.6828(10)Å c=14.3427(8)Å
α=85.970(6)° β=83.926(6)° γ=82.198(7)°
C20H18CuN6O3S,3(O)
C20H18CuN6O3S,3(O)
RSC Adv. (2015)
a=8.1557(18)Å b=11.023(3)Å c=14.092(3)Å
α=104.400(13)° β=93.284(13)° γ=99.663(14)°
C24H18CuN6O3S
C24H18CuN6O3S
RSC Adv. (2015)
a=7.8808(6)Å b=10.9146(9)Å c=14.0860(9)Å
α=99.182(3)° β=94.515(3)° γ=102.572(3)°
C26H18CuN6O3S
C26H18CuN6O3S
RSC Adv. (2015)
a=7.7532(6)Å b=12.0716(9)Å c=14.2178(9)Å
α=103.320(4)° β=99.041(4)° γ=105.263(4)°
C38H44N2Se
C38H44N2Se
Dalton transactions (Cambridge, England : 2003) (2014) 43, 25 9431-9437
a=9.6138(3)Å b=11.1782(5)Å c=17.0830(7)Å
α=89.666(3)° β=75.815(3)° γ=65.343(3)°
C19H22BrNSe
C19H22BrNSe
Dalton transactions (Cambridge, England : 2003) (2014) 43, 25 9431-9437
a=9.5735(5)Å b=16.5118(9)Å c=23.4372(13)Å
α=90.00° β=90.00° γ=90.00°
C19H22INSe
C19H22INSe
Dalton transactions (Cambridge, England : 2003) (2014) 43, 25 9431-9437
a=9.5672(2)Å b=17.2716(2)Å c=23.5022(5)Å
α=90.00° β=90.00° γ=90.00°
C20H22N2Se2
C20H22N2Se2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 25 9431-9437
a=10.0205(6)Å b=11.4514(8)Å c=16.4769(12)Å
α=90.00° β=97.148(6)° γ=90.00°
<i>O</i>,<i>O</i>'-Dimethyl [(2,3,4,5,6-pentafluorophenylhydrazinyl]phosphonate
C8H8F5N2O3P
Acta Crystallographica Section C (2019) 75, 10
a=10.5273(2)Å b=10.3266(3)Å c=21.1193(5)Å
α=90° β=92.647(2)° γ=90°
6-Amino-5-chloro-2,4-dimethylpyridin-1-ium 5-chloro-2-hydroxybenzoate
C6H9ClN3,C7H4ClO3
Acta Crystallographica Section C (2017) 73, 11 862-868
a=9.3874(4)Å b=10.5102(4)Å c=15.4295(6)Å
α=71.1670(10)° β=83.335(2)° γ=87.7300(10)°
2-Amino-4,6-dimethoxypyrimidin-1ium thiophene-2-carboxylate
C6H10N3O2,C5H3O2S
Acta Crystallographica Section C (2017) 73, 11 862-868
a=6.7335(3)Å b=7.6307(4)Å c=25.0638(10)Å
α=90° β=93.928(4)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--3-bromothiophene-2-carboxylic acid (1/1)
C5H3BrO2S,C6H8ClN3
Acta Crystallographica Section C (2018) 74, 9
a=7.5237(4)Å b=7.5739(4)Å c=12.5089(7)Å
α=79.629(2)° β=79.596(2)° γ=75.895(2)°
4-Amino-5-chloro-2,6-dimethylpyrimidine--5-chlorothiophene-2-carboxylic acid (1/1)
C6H8ClN3,C5H3ClO2S
Acta Crystallographica Section C (2018) 74, 9
a=7.2182(3)Å b=7.6364(3)Å c=12.7516(6)Å
α=90.707(2)° β=102.629(2)° γ=105.338(2)°
4-Amino-5-chloro-2,6-dimethylpyrimidine---2,4-dichlorobenzoic acid (1/1)
C6H8ClN3,C7H4Cl2O2
Acta Crystallographica Section C (2018) 74, 9
a=7.3015(4)Å b=7.5060(6)Å c=14.9665(8)Å
α=92.539(5)° β=98.522(5)° γ=113.657(7)°
(<i>E</i>)-4-Bromo-2-[(2-hydroxyphenylimino)methyl]-6-methoxyphenol
C14H12BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.297(2)Å b=15.095(3)Å c=6.4166(13)Å
α=90° β=91.329(6)° γ=90°
(<i>E</i>)-4-Bromo-2-methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H14BrNO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=6.4158(3)Å b=7.3886(4)Å c=15.2636(7)Å
α=87.081(3)° β=87.488(3)° γ=77.948(3)°
(<i>E</i>)-<i>N</i>-(3,4-Dimethylisoxazol-5-yl)-4-[(2-hydroxybenzylidene)amino]benzenesulfonamide
C18H17N3O4S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=20.344(2)Å b=9.6384(9)Å c=9.4430(10)Å
α=90° β=101.060(3)° γ=90°
(<i>E</i>)-4-[(5-Bromo-2-hydroxy-3-methoxybenzylidene)amino]-<i>N</i>-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide
C19H18BrN3O5S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=13.6043(11)Å b=12.2399(7)Å c=12.9506(9)Å
α=90° β=103.854(2)° γ=90°
(<i>E</i>)-2-Methoxy-6-[(2-methoxyphenylimino)methyl]phenol
C15H15NO3
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=23.689(2)Å b=7.6951(7)Å c=7.3488(7)Å
α=90° β=90° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(2-hydroxybenzylidene)amino)]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H19NO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
(<i>E</i>)-3-Benzoyl-2-[(5-fluoro-2-hydroxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C22H18FNO2S
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.5004(8)Å b=14.2911(11)Å c=13.6497(9)Å
α=90° β=97.524(2)° γ=90°
(<i>E</i>)-[(2-Hydroxyphenylimino)methyl]phenol
C13H11NO2
Acta Crystallographica Section C (2018) 74, 10 1094-1104
a=9.0479(7)Å b=10.1564(8)Å c=12.3659(10)Å
α=69.677(6)° β=89.940(6)° γ=77.004(6)°
4-Amino-5-chloro-2,6-dimethylpyrimidine--5-methylthiophene-2-carboxylic acid (1/1)
C6H8ClN3,C6H6O2S
Acta Crystallographica Section C (2018) 74, 9
a=8.273(3)Å b=12.746(4)Å c=13.320(4)Å
α=90° β=102.390(5)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--2-aminobenzoic acid (1/1)
C6H8ClN3,C7H7NO2
Acta Crystallographica Section C (2018) 74, 9
a=8.0965(2)Å b=7.2427(3)Å c=24.0738(9)Å
α=90° β=90.831(3)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--benzoic acid (1/1)
C6H8ClN3,C7H6O2
Acta Crystallographica Section C (2018) 74, 9
a=10.1421(5)Å b=10.4218(5)Å c=13.2681(6)Å
α=90° β=107.804(5)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--4-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=8.0223(5)Å b=13.6901(10)Å c=13.3346(10)Å
α=90° β=101.557(7)° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--2-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=7.3992(2)Å b=13.9842(4)Å c=26.9897(8)Å
α=90° β=90° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--3-methylbenzoic acid (1/1)
C6H8ClN3,C8H8O2
Acta Crystallographica Section C (2018) 74, 9
a=8.45240(10)Å b=13.5387(2)Å c=24.9813(3)Å
α=90° β=90° γ=90°
4-Amino-5-chloro-2,6-dimethylpyrimidine--4-aminobenzoic acid (1/1)
C6H8ClN3,C7H7NO2
Acta Crystallographica Section C (2018) 74, 9
a=7.8899(2)Å b=13.2361(3)Å c=13.3212(3)Å
α=90° β=101.254(2)° γ=90°
1-(4-Methylphenyl)-4,9-dihydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H15N3
Acta Crystallographica Section C (2016) 72, 9
a=6.6676(17)Å b=26.571(8)Å c=7.912(2)Å
α=90° β=104.561(9)° γ=90°
(<i>E</i>)-1-[(2-Chloroquinolin-3-yl)methylidene]-2-(4-methylphenyl)hydrazine
C17H14ClN3
Acta Crystallographica Section C (2016) 72, 9
a=14.730(6)Å b=12.413(5)Å c=16.464(5)Å
α=90° β=90° γ=90°
6-Methyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H13N3
Acta Crystallographica Section C (2016) 72, 9
a=29.9202(12)Å b=29.9202(12)Å c=7.3811(3)Å
α=90° β=90° γ=120°
1-Phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C16H11N3
Acta Crystallographica Section C (2016) 72, 9
a=25.145(2)Å b=16.9623(19)Å c=16.8138(19)Å
α=90° β=90° γ=90°
4-Amino-<i>N</i>-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide--3,5-dinitrobenzoic acid (1/1)
C11H13N3O3S,C7H4N2O6
Acta Crystallographica Section C (2016) 72, 8
a=7.8189(4)Å b=8.6727(5)Å c=15.9304(10)Å
α=96.439(5)° β=94.458(5)° γ=107.477(5)°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazolium 2,4,6-trinitrophenolate
C9H8FN2,C6H2N3O7
Acta Crystallographica Section C (2016) 72, 8
a=11.8062(7)Å b=8.0061(4)Å c=17.6442(12)Å
α=90° β=107.009(7)° γ=90°
Aquadichlorido{1,1-[(pyridine-2,6-diyl-κ<i>N</i>)bis(methylene)]bis(4-butyl-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione-κ<i>N</i>^2^)}cobalt(II)
C19H29Cl2CoN7OS2
Acta Crystallographica Section E (2020) 76, 11 1757-1761
a=26.3412(8)Å b=11.4270(3)Å c=8.6226(3)Å
α=90° β=90.465(3)° γ=90°
3-Butyl-2,6-bis(4-fluorophenyl)piperidin-4-one
C21H23F2NO
Acta Crystallographica Section E (2020) 76, 5 651-655
a=5.4945(3)Å b=25.0707(13)Å c=12.9811(9)Å
α=90° β=93.497(6)° γ=90°
(Acetonitrile)[2-methoxy-<i>N</i>,<i>N</i>-bis(quinolin-2-ylmethyl)ethylamine]copper(II) bis(perchlorate)
C25H26CuN4O,2(ClO4)
Acta Crystallographica Section E (2018) 74, 8 1138-1141
a=11.3597(3)Å b=16.9611(4)Å c=14.5514(3)Å
α=90° β=95.622(2)° γ=90°
(Acetato-κ^2^<i>O</i>,<i>O</i>)(methanol-κ<i>O</i>)[tris(pyridin-2-ylmethyl)amine-κ^4^<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>''']manganese(II) tetraphenylborate
C21H25MnN4O3,C24H20B
Acta Crystallographica Section E (2018) 74, 8 1075-1078
a=11.3885(8)Å b=11.7598(7)Å c=15.6703(10)Å
α=82.041(5)° β=70.671(6)° γ=85.870(5)°
Clozapinium 3,5-dinitrobenzoate dimethyl sulfoxide monosolvate
C18H20ClN4,C7H3N2O6,C2H6OS
Acta Crystallographica Section E (2015) 71, 4 406-413
a=15.3593(2)Å b=15.7685(2)Å c=11.8679(2)Å
α=90° β=91.8097(14)° γ=90°
Clozapinium hydrogen maleate 0.21-hydrate
C18H20ClN4,C4H3O4,0.21(H2O)
Acta Crystallographica Section E (2015) 71, 4 406-413
a=9.7166(3)Å b=9.9699(2)Å c=23.1059(6)Å
α=90° β=96.800(3)° γ=90°
Clozapinium 2-hydroxybenzoate
C18H20ClN4,C7H5O3
Acta Crystallographica Section E (2015) 71, 4 406-413
a=17.4296(5)Å b=15.3728(5)Å c=8.6359(3)Å
α=90° β=90.325(3)° γ=90°
Methyl 5-bromo-2-[(2-chloroquinolin-3-yl)methoxy]benzoate
C18H13BrClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=7.3185(4)Å b=18.4177(7)Å c=11.7870(5)Å
α=90° β=93.609(4)° γ=90°
2-Chloro-3-[(naphthalen-1-yloxy)methyl]quinoline
C20H14ClNO
Acta Crystallographica Section E (2015) 71, 6 609-617
a=5.3165(3)Å b=10.5098(4)Å c=13.6201(7)Å
α=90° β=98.527(5)° γ=90°
Methyl 5-bromo-2-[(2-chloro-6-methylquinolin-3-yl)methoxy]benzoate
C19H15BrClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=15.1920(3)Å b=11.98641(19)Å c=19.0307(3)Å
α=90° β=90° γ=90°
Methyl 2-[(2-chloro-6-methylquinolin-3-yl)methoxy]benzoate
C19H16ClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=13.5860(3)Å b=15.5857(2)Å c=30.9389(5)Å
α=90° β=90° γ=90°
{5-[(2-Chloroquinolin-3-yl)methoxy]-4-(hydroxymethyl)-6-methyl-pyridin-3-yl}methanol
C18H17ClN2O3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=9.7866(3)Å b=15.3336(4)Å c=10.6570(3)Å
α=90° β=92.381(3)° γ=90°
3-Chloro-2-(4-methylphenyl)-2<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H12ClN3
Acta Crystallographica Section E (2015) 71, 5 567-570
a=10.2194(4)Å b=13.4661(5)Å c=10.4600(4)Å
α=90° β=102.780(4)° γ=90°
2-Chloro-3-(dimethoxymethyl)-6-methoxyquinoline
C13H14ClNO3
Acta Crystallographica Section E (2015) 71, 5 o364-o365
a=27.1156(9)Å b=7.1401(3)Å c=13.0804(5)Å
α=90° β=90° γ=90°
(<i>E</i>)-2-Fluorobenzaldehyde (pyridin-2-yl)hydrazone
C12H10FN3
Acta Crystallographica Section E (2015) 71, 5 o362-o363
a=3.85166(14)Å b=23.1757(7)Å c=11.4227(4)Å
α=90° β=99.278(4)° γ=90°
Nonacyclo[14.6.6.6^5,12^.0^2,15^.0^4,13^.0^6,11^.0^17,22^.0^23,28^.0^29,34^]tetratriaconta-2(15),4(13),6,8,10,17,19,21,23,25,27,29(34),30,32-tetradecaene-3,14-dione
C34H20O2
Acta Crystallographica Section E (2016) 72, 12 1734-1738
a=10.3419(4)Å b=11.7885(6)Å c=19.2267(11)Å
α=77.606(5)° β=89.306(4)° γ=86.658(4)°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C18H18ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=6.7150(6)Å b=10.9591(13)Å c=11.1704(10)Å
α=72.162(9)° β=79.721(7)° γ=76.873(8)°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-di-<i>p</i>-tolylpiperidin-4-one
C20H22ClNO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.0578(2)Å b=22.6513(4)Å c=5.93756(8)Å
α=90° β=90° γ=90°
3-Chloro-3-methyl-<i>r</i>-2,<i>c</i>-6-bis(4-chlorophenyl)piperidin-4-one
C18H16Cl3NO
Acta Crystallographica Section E (2017) 73, 2 107-111
a=13.2430(4)Å b=22.3945(6)Å c=5.81947(14)Å
α=90° β=90° γ=90°
3-(2-Chloroethyl)-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C19H20ClNO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=11.3306(3)Å b=13.3638(4)Å c=10.9821(3)Å
α=90° β=91.996(2)° γ=90°
3-(2-chloroethyl)-<i>r</i>-2,<i>c</i>-6-bis(4-fluorophenyl)piperidin-4-one
C19H18ClF2NO
Acta Crystallographica Section E (2018) 74, 4 483-486
a=5.5105(2)Å b=24.2612(6)Å c=12.8622(3)Å
α=90° β=93.809(3)° γ=90°
(3a<i>R</i>*,7a<i>S</i>*)-2-(2,6-Dioxopiperidin-3-yl)hexahydro-1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione
C13H16N2O4
Acta Crystallographica Section E (2018) 74, 11 1595-1598
a=11.4519(3)Å b=9.2370(3)Å c=11.8727(4)Å
α=90° β=90.475(3)° γ=90°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°
4-Methyl-2-oxo-2<i>H</i>-chromene-7,8-diyl diacetate
C14H12O6
Acta Crystallographica Section E (2016) 72, 5 704-708
a=7.3722(10)Å b=8.7235(7)Å c=11.7032(15)Å
α=69.263(10)° β=87.519(11)° γ=69.113(10)°
4-Methyl-2-oxo-2<i>H</i>-chromene-7,8-diyl bis(pent-4-ynoate)
C20H16O6
Acta Crystallographica Section E (2016) 72, 5 704-708
a=5.2785(3)Å b=16.3785(8)Å c=20.0502(11)Å
α=90° β=95.992(2)° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(2-methylphenyl)prop-2-en-1-one
C14H11ClOS
Acta Crystallographica Section E (2016) 72, 8 1153-1158
a=14.7179(7)Å b=7.5783(4)Å c=11.5451(5)Å
α=90° β=102.999(4)° γ=90°
2-Benzoylamino-<i>N</i>'-(4-hydroxybenzylidene)-3-(thiophen-2-yl)prop-2-enohydrazide
C21H17N3O3S
Acta Crystallographica Section E (2016) 72, 8 1099-1102
a=22.5212(7)Å b=10.1879(4)Å c=17.3592(5)Å
α=90° β=105.801(3)° γ=90°
(2<i>E</i>)-1-(Anthracen-9-yl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one
C26H22O
Acta Crystallographica Section E (2016) 72, 8 1153-1158
a=9.0150(4)Å b=14.0601(6)Å c=16.2611(8)Å
α=105.146(4)° β=95.967(4)° γ=98.057(4)°
6-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4(3<i>H</i>)-one
C15H12N4O4
Acta Crystallographica Section E (2016) 72, 7 969-971
a=12.1863(9)Å b=10.7079(8)Å c=11.1726(8)Å
α=90° β=105.412(8)° γ=90°
1-(2-Hydroxy-5-methoxyphenyl)ethanone 4,4-dimethylthiosemicarbazone
C12H17N3O2S
Acta Crystallographica Section E (2015) 71, 11 o811-o812
a=15.7097(12)Å b=7.8300(5)Å c=21.2351(19)Å
α=90° β=92.635(8)° γ=90°